Acute response in vivo of a fiber-optic sensor for continuous glucose monitoring from canine studies on point accuracy

Sensors

Volumn 10, Issue 8, 2010, Pages 7789-7802

  Liao, Kuo Chih ^a   Chang, Shih Chieh ^a   Chiu, Cheng Yang ^a   Chou, Yu Hsiang ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Calibration; Clarke error grid analysis; Fiber optic sensor; In vivo glucose monitoring; Point accuracy

Indexed keywords

CONTINUOUS GLUCOSE MONITORING; CONVENTIONAL SYSTEMS; ERROR GRID ANALYSIS; GLUCOSE CONCENTRATION; GLUCOSE MONITORING; LINEAR CORRELATION; PEARSON CORRELATION COEFFICIENTS; POINT ACCURACY;

CORRELATION METHODS; FIBER OPTIC SENSORS; GLUCOSE; PLASMAS;

CALIBRATION;

AMBULATORY MONITORING; ANIMAL; ARTICLE; DOG; FIBER OPTICS; GENETIC PROCEDURES; GLUCOSE BLOOD LEVEL; INSTRUMENTATION; METHODOLOGY; THEORETICAL MODEL;

ANIMALS; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; DOGS; FIBER OPTIC TECHNOLOGY; MODELS, THEORETICAL; MONITORING, AMBULATORY;

EID: 77957238796     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s100807789     Document Type: Article

References (26)

1. Pickup, J.C. In vivo glucose monitoring: Sense and sensorobility. Diabetes Care 1993, 16, 535-539.
2. Wilson, G.S.; Reach, G. Diabetes and glucose sensors. Anal. Chem. 1992, 64, 381A-384A.
3. Diabetes Control and Complication Trials Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329, 977-986.
4. UK Prospective Diabetes Study Group(UKPDS 33). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352, 837-853.
5. Wentholt, I.; Hoekstra, J.; DeVries, J. A critical appraisal of the continuous error grid analysis. Diabetes Care 2006, 29, 1805-1811.
6. Steil, G.M.; Panteleon, A.E.; Rebrin, K. Close-loop insulin delivery-The path to physiological glucose control. Advan. Drug Delivery Rev. 2004, 56, 125-144.
7. Clarke, W.L. The original Clarke error grid analysis (EGA). Diabetes Technol. Ther. 2005, 7, 776-779.
8. Steil, G.M.; Rebrin, K.; Mastrototaro, J.J. Metabolic modeling and the close-loop insulin delivery problem. Diabetes Res. Clin. Pract. 2006, 74, S183-S186.
9. Steil, G.M.; Rebrin, K.; Janowski, R.; Darwin, C.; Saad, M.F. Modeling β-cell secretion-Implications for closed-loop glucose homeostasis. Diabetes Technol. Ther. 2003, 5, 953-964.
10. Liao, K.C.; Hogen-Esch, T.; Richmond, F.J.; Marcu, L.; Clifton, W.; Loeb, G.E. Percutaneous fiber-optic sensor for chronic glucose monitoring in vivo. Biosensor. Bioelectron.2008, 23, 1458-1465.
11. Liao, K.C.; Hogen-Esch, T.; Richmond, F.J.; Marcu, L.; Loeb, G.E. Design and Fabrication of Disposable, Percutaneous Chemical Sensors. In Proceedings of Optical Fibers and Sensors for Medical Application V, SPIE, Bellingham, WA, USA, July 2005; Volume 5691, pp. 129-145.
12. Garg, S.; Zisser, H.; Schwartz, S.; Bailey, T.; Kaplan, R.; Ellis, S.; Jovanovic, L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: A randomized controlled trial. Diabetes Care 2006, 29, 44-50.
13. Garg, S.K.; Potts, R.O.; Ackerman, N.R.; Fermi, S.J.; Tamada, J.A.; Chase, H.P. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose result in young subjects with type 1 diabetes. Diabetes Care 1999, 130, 1708-1714.
14. Shichri, M.; Sakakida, M.; Nishida, K.; Shioda, S. Enhanced, simplified glucose sensors: Long-term clinical application of wearable artificial endocrine pancreas. Artific. Organ. 1998, 22, 32-42.
15. Bindra, D.S.; Zhang, Y.; Wilson, G.S.; Sternberg, R.; Thevenot, D.R.; Moatti, D.; Reach, G. Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring. Anal. Chem. 1991, 63, 1692-1696.
16. Boyne, M.S.; Silver, D.M.; Kaplan, J.; Saudek, C.D. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003, 52, 2790-2794.
17. Aussedat, B.; Dupire-Angel, M.; Gifford, R.; Klein, J.C.; Wilson, G.S.; Reach, G. Interstitial glucose concentration and glycemia: Implications for continuous subcutaneous glucose monitoring. Amer. J. Physiol-Endocr. Metab. 2000, 278, E716-728.
18. Kulcu, E.; Potts, R.O.; Tamada, J.A.; Lesho, M.J.; Reach, G. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003, 26, 2405-2409.
19. Rebrin, K.; Steil, G.M. Can interstitial glucose assessment replace blood glucose measurement? Diabetes Technol. Ther. 2000, 2, 461-471.
20. Rebrin, K.; Steil, G.M.; van Antwerp, W.P.; Mastrototaro, J.J. Subcutaneous glucose predicts plasma glucose independent of insulin: Implications for continuous monitoring. Am. J. Physiol-Endocrinol. Metab. 1999, 277, E561-E571.
21. Panteleon, A.E.; Rebrin, K.; Steil, G.M. The role of the independent variable to glucose sensor calibration. Diabetes Technol. Ther. 2003, 5, 401-410.
22. Hecht, E. The propagation of light. In Optics, 4th ed.; Addison Wesley: San Francisco, CA, USA, 2002; pp. 86-148.
23. Labow, R.S.; Erfle, D.J.; Santerre, J.P. Neutrophil-mediated degradation of segmented polyurethanes. Biomaterials 1995, 16, 51-59.
24. Heninger, N.; Woderer, S.; Kloetzer, H.M.; Staib, A.; Gillen, R.; Li, L.; Yu, X.; Norbert, G.; Kraenzlin, B.; Pill, J. Tissue response to subcutaneous implantation of glucose-oxidase-based glucose sensor in rats. Biosensor. Bioelectron. 2007, 233, 26-34.
25. Klueh, U.; Kaur, M.; Qiao, Y.; Kreutzer, D.L. Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo. Biomaterials 2010, 31, 4540-4551.
26. Guerci, B.; Benichu, M.; Floriot, M.; Jellimann, S.; Bohme, P.; Drouin, P.; Durain, D. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analog. Diabetes Care 2003, 26, 582-589.